Molecular and Phenotypic Patterns of Antibiotic-Resistant E. coli in Jordan
DOI:
https://doi.org/10.35516/jmj.v59i5.4271الكلمات المفتاحية:
E. coli، AmpC beta lactamas، Carbapenemases، Fluoroquinolones، Aminoglycosides، CMY، aac6’-Ib-cr، GyrAالملخص
Antibiotic resistance accounts for over 50% of Escherichia coli (E. coli) infections, mediated by extended-spectrum β-lactamases (ESBLs), AmpC β-lactamases, carbapenemase, and other mechanisms. Data on AmpC, carbapenemase, aminoglycosides, and quinolones resistance of E. coli in Jordan are minimal. This study aimed to determine the molecular and phenotypic prevalence of antibiotic-resistant E. coli in Jordan. Methods: 153 E. coli isolates collected from multiple Jordanian hospitals were tested for species identification, antibiotic susceptibility, and resistance genes. Results: 153 E. coli isolates were collected with a mean age of 47.09 ± 25.32. Most samples were collected from the emergency department (29.7%) and urine samples were the major source (82.9%). For AmpC detection, 67 (57.8%) samples were resistant to cefoxitin, 13 (23.2%) were positive for AmpC disk test, all tested samples were negative for CMY-1 gene, while 15 (14.4%) samples were positive for CMY-2 gene. Regarding aminoglycoside resistance, 54 (38 %) strains were resistant to gentamycin, 3 (2.1%) were resistant to amikacin, and 94 (61.4%) samples had aac6’-Ib-cr gene. For fluoroquinolones resistance, 92 (65.7 %) isolates were resistant to ciprofloxacin, 65 (47.1%) were resistant to levofloxacin, and 102 (98%) isolates were positive for the gyrA gene. Finally, 3 (2%) isolates were resistant to imipenem and meropenem, however, carbapenemase genes including KPC, OXA-48, IMP, and VIM genes were negative in all samples. Conclusion: Understanding the molecular and phenotypic characteristics of antibiotic-resistant E. coli will help to guide proper antibiotic therapy and combat microbial resistance in Jordan.
المراجع
Campbell NA, Reece JB. International Edition Biology.
Stecher B, Hardt WD. The role of microbiota in infectious disease. Trends in microbiology. 2008 Mar 1;16(3):107-14.
Pitout JD. Extraintestinal pathogenic Escherichia coli: an update on antimicrobial resistance, laboratory diagnosis and treatment. Expert review of anti-infective therapy. 2012 Oct 1;10(10):1165-76.
World Health Organization. February 2017. WHO publishes list of bacteria for which new antibiotics are urgently needed. World Health Organization, Geneva, Switzerland. http://www. who. int/mediacentre/news/releases/2017/bacteria-antibiotics-needed/en. 27.
Ambler RP. The structure of β-lactamases. Philosophical Transactions of the Royal Society of London. B, Biological Sciences. 1980 May 16;289(1036):321-31.
Drawz, S. M., & Bonomo, R. A. Three decades of β-lactamase inhibitors. Clinical microbiolog reviews,. 2010; 23(1), 160-201.
Jacoby GA. AmpC β-lactamases. Clinical microbiology reviews. 2009 Jan;22(1):161-82.
Nordmann P, Dortet L, Poirel L. Carbapenem resistance in Enterobacteriaceae: here is the storm!. Trends in molecular medicine. 2012 May 1;18(5):263-72.
Allocati, N., Masulli, M., Alexeyev, M. F., & Di Ilio, C. Escherichia coli in Europe: an overview. International journal of environmental research and public health,. 2013;10(12), 6235-6254.
Holmes AH, Moore LS, Sundsfjord A, Steinbakk M, Regmi S, Karkey A, Guerin PJ, Piddock LJ. Understanding the mechanisms and drivers of antimicrobial resistance. The Lancet. 2016 Jan 9;387(10014):176-87.
Belaynehe KM, Shin SW, Hong-Tae P, Yoo HS. Occurrence of aminoglycoside-modifying enzymes among isolates of Escherichia coli exhibiting high levels of aminoglycoside resistance isolated from Korean cattle farms. FEMS Microbiology Letters. 2017 Jul;364(14):fnx129.
Davis MA, Baker KN, Orfe LH, Shah DH, Besser TE, Call DR. Discovery of a gene conferring multiple-aminoglycoside resistance in Escherichia coli. Antimicrobial agents and chemotherapy. 2010 Jun;54(6):2666-9.
Garneau-Tsodikova S, Labby KJ. Mechanisms of resistance to aminoglycoside antibiotics: overview and perspectives. Medchemcomm. 2016;7(1):11-27.
Polsfuss S, Bloemberg GV, Giger J, Meyer V, Böttger EC, Hombach M. Practical approach for reliable detection of AmpC beta-lactamase-producing Enterobacteriaceae. Journal of clinical microbiology. 2011 Aug;49(8):2798-803.
Black JA, Moland ES, Thomson KS. AmpC disk test for detection of plasmid-mediated AmpC β-lactamases in Enterobacteriaceae lacking chromosomal AmpC β-lactamases. Journal of clinical microbiology. 2005 Jul;43(7):3110-3.
Yong D, Lee Y, Jeong SH, Lee K, Chong Y. Evaluation of double-disk potentiation and disk potentiation tests using dipicolinic acid for detection of metallo-β-lactamase-producing Pseudomonas spp. and Acinetobacter spp. Journal of clinical microbiology. 2012 Oct;50(10):3227-32.
Heisig P. Genetic evidence for a role of parC mutations in development of high-level fluoroquinolone resistance in Escherichia coli. Antimicrobial agents and chemotherapy. 1996 Apr;40(4):879-85.
Weigel LM, Steward CD, Tenover FC. gyrA mutations associated with fluoroquinolone resistance in eight species of Enterobacteriaceae. Antimicrobial Agents and Chemotherapy. 1998 Oct 1;42(10):2661-7.
Hasman H, Mevius D, Veldman K, Olesen I, Aarestrup FM. β-Lactamases among extended-spectrum β-lactamase (ESBL)-resistant Salmonella from poultry, poultry products and human patients in The Netherlands. Journal of Antimicrobial Chemotherapy. 2005 Jul 1;56(1):115-21.
Shehabi AA, Mahafzah AM, Al Khalili KZ. Antimicrobial resistance and plasmid profiles of urinary Escherichia coli isolates from Jordanian patients. East Mediterr Health J. 2004 May;10(3):322-8.
Al-Mardeni RI, Batarseh A, Omaish L, Shraideh M, Batarseh B, Unis N. Empirical treatment for pediatric urinary tract infection and resistance patterns of uropathogens, in Queen Alia hospital and prince A'Isha military center-Jordan. Saudi Journal of Kidney Diseases and Transplantation. 2009 Jan 1;20(1):135-9.
Shaqra A. Occurrence and antibiotic sensitivity of Enterobacteriaceae isolated from a group of Jordanian patients with community acquired urinary tract infections. Cytobios. 2000 Jan 1;101(396):15-21.
Murshidi MS, Farah NB. Urinary tract infections in adult and adolescent males of a developing community: pattern, bacteriology and genito-urinary predisposing factors. Archivos Espanoles de Urologia. 2002 Dec 1;55(10):288-93.
Hayajneh WA, Hajj A, Hulliel F, Sarkis DK, Irani-Hakimeh N, Kazan L, Badal RE. Susceptibility trends and molecular characterization of Gram-negative bacilli associated with urinary tract and intra-abdominal infections in Jordan and Lebanon: SMART 2011–2013. International Journal of Infectious Diseases. 2015 Jun 1;35:56-61.
Al-Asoufi A, Khlaifat A, Tarawneh AA, Alsharafa K, Al-Limoun M, Khleifat K. Bacterial Quality of Urinary Tract Infections in Diabetic and Non Diabetics of the Population of Ma'an Province, Jordan. Pakistan journal of biological sciences: PJBS. 2017 Jan 1;20(4):179-88.
Youssef M, Shurman A, Bougnoux ME, Rawashdeh M, Bretagne S, Strockbine N. Bacterial, viral and parasitic enteric pathogens associated with acute diarrhea in hospitalized children from northern Jordan. FEMS Immunology & Medical Microbiology. 2000 Jul 1;28(3):257-63.
Shehabi AA, Bulos NK, Hajjaj KG. Characterization of diarrhoeagenic Escherichia coli isolates in Jordanian children. Scandinavian journal of infectious diseases. 2003 Jan 1;35(6-7):368-71.
Shehabi AA, Odeh JF, Fayyad M. Characterization of antimicrobial resistance and class 1 integrons found in Escherichia coli isolates from human stools and drinking water sources in Jordan. Journal of Chemotherapy. 2006 Oct 1;18(5):468-72.
Nimri LF, Elnasser Z, Batchoun R. Polymicrobial infections in children with diarrhoea in a rural area of Jordan. FEMS Immunology & Medical Microbiology. 2004 Oct 1;42(2):255-9.
Nimri LF, Elnasser Z, Batchoun R. Polymicrobial infections in children with diarrhoea in a rural area of Jordan. FEMS Immunology & Medical Microbiology. 2004 Oct 1;42(2):255-9.
Nimri LF, Elnasser Z, Batchoun R. Polymicrobial infections in children with diarrhoea in a rural area of Jordan. FEMS Immunology & Medical Microbiology. 2004 Oct 1;42(2):255-9.
Al-Shara M. A five-year review on the etiology and antimicrobial susceptibility pattern of otitis media pathogens in Jordanian children. Oman Medical Journal. 2012 Sep;27(5):358.
Nimri LF, Rawashdeh M, Meqdam MM. Bacteremia in children: etiologic agents, focal sites, and risk factors. J Trop Pediatr. 2001;47(6):356-60.
Mohammad A. Bacteremia among Jordanian children at Princess Rahmah Hospital: Pathogens and antimicrobial susceptibility patterns. Iran J Microbiol. 2010;2:22-6.
Yusef D., Jahmani T., Kailani S., Al-Rawi R., Khasawneh W. Community-acquired serious bacterial infections in the first 90 days of life: A revisit in the era of multi-drug-resistant organisms. World J. Pediatr. 2019;15:580–585.
Kaplan NM, Smadi AA, Al-Taani MI, El-Qudah MA. Microbiology of wound infection after caesarean section in a Jordanian hospital. East Mediterr Health J. 2003;9(5-6):1068-74.
Abbara A, Al-Harbat N, Karah N, Abo-Yahya B, El-Amin W, Hatcher J, at al. Antimicrobial Drug Resistance among Refugees from Syria, Jordan. Emerg Infect Dis. 2017;23(5):885-886.
Abu Salah MAA, Badran EF, Shehabi AA. High incidence of multidrug resistant Escherichia coli producing CTX-M-type ESBLs colonizing the intestine of Jordanian infants. IAJAA. 2013;3;1-7.
Badran EF, Din RAQ, Shehabi AA. Low intestinal colonization of Escherichia coli clone ST131 producing CTX-M-15 in Jordanian infants. J Med Microbiol. 2016;65(2):137-141.
Al-Dweik MR, Shehabi AA. Common antimicrobial resistance phenotypes and genotypes of fecal Escherichia coli isolates from a single family over a 6-month period. Microb Drug Resist. 2009;15:103-7.
Borg MA, van de Sande-Bruinsma N, Scicluna E, de Kraker M, Tiemersma E, Monen J, at al. Grundmann H; ARMed Project Members and Collaborators.Antimicrobial resistance in invasive strains of Escherichia coli from southern and eastern Mediterranean laboratories. Clin Microbiol Infect. 2008;14:789-96.
Borg MA, Scicluna E, de Kraker M, van de Sande-Bruinsma N, Tiemersma E, Gür D, at al. Antibiotic resistance in the southeastern Mediterranean--preliminary results from the ARMed project. Euro Surveill. 2006;11:164-7.
Alshara M. Antimicrobial resistant pattern of Escherichia coli strains isolated from pediatric patients in Jordan. Acta Med Iran. 2011;49:293-5.
Al-Tamimi M, Abu-Raideh J, Albalawi H, Shalabi M, Saleh S. Effective Oral Combination Treatment for Extended-Spectrum Beta-Lactamase-Producing Escherichia coli. Microb Drug Resist. 2019;25(8):1132-1141.
Nairoukh, Y.R.; Mahafzah, A.M.; Irshaid, A.; Shehabi, A.A. Molecular Characterization of Multidrug Resistant Uropathogenic E. coli Isolates from Jordanian Patients. Open Microbiol. J. 2018, 12, 1–7
Malkawi HI, Youssef MT. Antibiotic susceptibility testing and plasmid profiles of Escherichia coli isolated from diarrhoeal patients. J Trop Pediatr. 1998;44:128-32.
Aqel AA, Meunier D, Alzoubi HM, Masalha IM, Woodford N. Detection of CTX-M-type extended-spectrum beta-lactamases among Jordanian clinical isolates of Enterobacteriaceae. Scand J Infect Dis. 2014;46(2):155-7.
Aqel AA, Findlay J, Al-Maayteh M, Al-Kaabneh A, Hopkins KL, Alzoubi H, et al Characterization of Carbapenemase-Producing Enterobacteriaceae from Patients in Amman, Jordan. Microb Drug Resist. 2018;24(8):1121-1127.
Adler A, Shklyar M, Schwaber MJ, Navon-Venezia S, Dhaher Y, Edgar R, et al. Introduction of OXA-48-producing Enterobacteriaceae to Israeli hospitals by medical tourism. J Antimicrob Chemother. 2011;66(12):2763-6.
